ammonium hydroxide has been researched along with Aura in 96 studies
azane : Saturated acyclic nitrogen hydrides having the general formula NnHn+2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hyperammonemia can occur after acute overdose or chronic use of valproic acid (VPA)." | 9.41 | Risk factors of hyperammonemia in epilepsy patients with valproic acid therapy. ( Kim, DW; Kwack, DW, 2023) |
| "Epileptic children treated with VPA and free of neurological disabilities are at risk for hyperammonemia that may be associated with hypocarnitinemia." | 9.14 | The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: relationship to blood carnitine status. ( Abdella, MM; Hamed, SA, 2009) |
| "Valproic acid (VPA)-induced hyperammonemia (HA) is a rare adverse effect reported even at therapeutic VPA levels." | 8.31 | Valproic acid-induced hyperammonemia in neuropsychiatric disorders: a 2-year clinical survey. ( Aghamollaii, V; Ghayyem, H; Hassani, M; Hosseini, H; Mayeli, M; Shafie, M; Shakiba, A, 2023) |
| "AbstractThe aim of this study was to explore the effect of lamotrigine (LTG) on blood ammonia level in patients with epilepsy and identify risk factors affecting blood ammonia level." | 8.12 | Risk factors of elevated blood ammonia level in epilepsy patients treated with lamotrigine. ( Chen, J; Chen, X; Chen, Y; Miao, J; Wang, R; Zeng, J; Zhuang, X, 2022) |
| "Valproic acid (VPA) is not only an antiepileptic drug but also a mood stabilizer for patients with bipolar disorder." | 7.96 | Association Between the Serum Carnitine Level and Ammonia and Valproic Acid Levels in Patients with Bipolar Disorder. ( Ishioka, M; Kubo, K; Miyazaki, K; Nakagami, T; Shimoda, K; Sugawara, N; Tarakita, N; Yasui-Furukori, N; Yokoyama, S, 2020) |
| "This study was aimed at identifying genetic and non-genetic risk factors for valproic acid (VPA)-induced hyperammonaemia in Chinese paediatric patients with epilepsy." | 7.88 | Risk Factors for Valproic Acid-induced Hyperammonaemia in Chinese Paediatric Patients with Epilepsy. ( Li, X; Zhang, T; Zhao, L; Zhu, X, 2018) |
| "Valproic acid (VPA), which is widely used to treat epilepsy, migraine, and bipolar disorder, can causes severe hyperammonemia." | 7.81 | Influence of glutamine synthetase gene polymorphisms on the development of hyperammonemia during valproic acid-based therapy. ( Hirai, K; Imai, K; Inoue, K; Inoue, Y; Itoh, K; Suzuki, E; Takahashi, T; Takahashi, Y; Tsuji, D; Yamamoto, Y, 2015) |
| "Valproic acid, a branched short-chain fatty acid, has numerous action mechanisms which turn it into a broad spectrum anticonvulsant drug and make its use possible in some other pathologies such as bipolar disorder." | 7.80 | Hyperammonemia associated with valproic acid concentrations. ( Alvariza, S; Fagiolino, P; Guevara, N; Ibarra, M; Magallanes, L; Maldonado, C; Olano, I; Olmos, I; Vázquez, M, 2014) |
| "Valproic acid, which is widely used to treat various types of epilepsy, may cause severe hyperammonemia." | 7.80 | 4217C>A polymorphism in carbamoyl-phosphate synthase 1 gene may not associate with hyperammonemia development during valproic acid-based therapy. ( Hayashi, H; Imai, K; Inoue, K; Inoue, Y; Itoh, K; Miyakawa, K; Suzuki, E; Takahashi, T; Takahashi, Y; Tsuji, D; Yamamoto, Y; Yazawa, R, 2014) |
| "Hyperammonemia has been reported to be associated with patients who receive valproic acid (VPA) therapy." | 7.80 | Risk factors of hyperammonemia in patients with epilepsy under valproic acid therapy. ( Chang, CC; Chang, WN; Chen, NC; Chuang, YC; Huang, CR; Lin, CH; Lu, CH; Lu, YT; Tseng, YL, 2014) |
| "In November 1996, a panel of pediatric neurologists met to update the consensus statement issued in 1989 by a panel of neurologists and metabolic experts on L-carnitine supplementation in childhood epilepsy." | 7.70 | L-carnitine supplementation in childhood epilepsy: current perspectives. ( Bohan, TP; Coulter, DL; De Vivo, DC; Dreifuss, FE; Greenwood, RS; Nordli, DR; Shields, WD; Stafstrom, CE; Tein, I, 1998) |
| "Results: Mild cognitive impairment - MCI was diagnosed in 4 patients (28." | 5.72 | HYPERAMMONAEMIA AND COGNITIVE IMPAIRMENT IN EPILEPSY PATIENTS TREATED WITH VALPROIC ACID - PRELIMINARY STUDY. ( Dutkiewicz, J; Pilut, D; Szczygieł-Pilut, EE; Zajączkowska-Dutkiewicz, A, 2022) |
| "Hyperammonemia can occur after acute overdose or chronic use of valproic acid (VPA)." | 5.41 | Risk factors of hyperammonemia in epilepsy patients with valproic acid therapy. ( Kim, DW; Kwack, DW, 2023) |
| " Three groups of patients were studied: (A) epileptic under phenytoin monotherapy (n = 31); (B) with bipolar disorder under valproic acid treatment (n = 28); (C) elderly (n = 41)." | 5.22 | Carnitine and/or Acetylcarnitine Deficiency as a Cause of Higher Levels of Ammonia. ( Fagiolino, P; González, R; Guevara, N; Maldonado, C; Queijo, C; Vázquez, M, 2016) |
| "Epileptic children treated with VPA and free of neurological disabilities are at risk for hyperammonemia that may be associated with hypocarnitinemia." | 5.14 | The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: relationship to blood carnitine status. ( Abdella, MM; Hamed, SA, 2009) |
| "Valproic acid (VPA) has been associated with hyperammonemia with and without encephalopathy." | 5.14 | Hyperammonemia following intravenous valproate loading. ( Beasley, MT; Cofield, S; DeWolfe, JL; Faught, E; Knowlton, RC; Limdi, NA, 2009) |
| "Valproic acid (VPA)-induced hyperammonemia (HA) is a rare adverse effect reported even at therapeutic VPA levels." | 4.31 | Valproic acid-induced hyperammonemia in neuropsychiatric disorders: a 2-year clinical survey. ( Aghamollaii, V; Ghayyem, H; Hassani, M; Hosseini, H; Mayeli, M; Shafie, M; Shakiba, A, 2023) |
| "AbstractThe aim of this study was to explore the effect of lamotrigine (LTG) on blood ammonia level in patients with epilepsy and identify risk factors affecting blood ammonia level." | 4.12 | Risk factors of elevated blood ammonia level in epilepsy patients treated with lamotrigine. ( Chen, J; Chen, X; Chen, Y; Miao, J; Wang, R; Zeng, J; Zhuang, X, 2022) |
| "Valproic acid (VPA) is not only an antiepileptic drug but also a mood stabilizer for patients with bipolar disorder." | 3.96 | Association Between the Serum Carnitine Level and Ammonia and Valproic Acid Levels in Patients with Bipolar Disorder. ( Ishioka, M; Kubo, K; Miyazaki, K; Nakagami, T; Shimoda, K; Sugawara, N; Tarakita, N; Yasui-Furukori, N; Yokoyama, S, 2020) |
| "This study was aimed at identifying genetic and non-genetic risk factors for valproic acid (VPA)-induced hyperammonaemia in Chinese paediatric patients with epilepsy." | 3.88 | Risk Factors for Valproic Acid-induced Hyperammonaemia in Chinese Paediatric Patients with Epilepsy. ( Li, X; Zhang, T; Zhao, L; Zhu, X, 2018) |
| "Valproic acid (VPA), which is widely used to treat epilepsy, migraine, and bipolar disorder, can causes severe hyperammonemia." | 3.81 | Influence of glutamine synthetase gene polymorphisms on the development of hyperammonemia during valproic acid-based therapy. ( Hirai, K; Imai, K; Inoue, K; Inoue, Y; Itoh, K; Suzuki, E; Takahashi, T; Takahashi, Y; Tsuji, D; Yamamoto, Y, 2015) |
| "Hyperammonemia has been reported to be associated with patients who receive valproic acid (VPA) therapy." | 3.80 | Risk factors of hyperammonemia in patients with epilepsy under valproic acid therapy. ( Chang, CC; Chang, WN; Chen, NC; Chuang, YC; Huang, CR; Lin, CH; Lu, CH; Lu, YT; Tseng, YL, 2014) |
| "Valproic acid, a branched short-chain fatty acid, has numerous action mechanisms which turn it into a broad spectrum anticonvulsant drug and make its use possible in some other pathologies such as bipolar disorder." | 3.80 | Hyperammonemia associated with valproic acid concentrations. ( Alvariza, S; Fagiolino, P; Guevara, N; Ibarra, M; Magallanes, L; Maldonado, C; Olano, I; Olmos, I; Vázquez, M, 2014) |
| "Valproic acid, which is widely used to treat various types of epilepsy, may cause severe hyperammonemia." | 3.80 | 4217C>A polymorphism in carbamoyl-phosphate synthase 1 gene may not associate with hyperammonemia development during valproic acid-based therapy. ( Hayashi, H; Imai, K; Inoue, K; Inoue, Y; Itoh, K; Miyakawa, K; Suzuki, E; Takahashi, T; Takahashi, Y; Tsuji, D; Yamamoto, Y; Yazawa, R, 2014) |
| "To determine whether children with epilepsy undergoing valproate (VPA) antiepileptic therapy and who are otherwise healthy have a lower serum level of carnitine (CAR) and a higher plasma level of plasma ammonia than do normal children." | 3.70 | Valproate therapy does not deplete carnitine levels in otherwise healthy children. ( Hirose, S; Mitsudome, A; Muta, Y; Ogawa, A; Tomoda, Y; Yasumoto, S, 1998) |
| "In November 1996, a panel of pediatric neurologists met to update the consensus statement issued in 1989 by a panel of neurologists and metabolic experts on L-carnitine supplementation in childhood epilepsy." | 3.70 | L-carnitine supplementation in childhood epilepsy: current perspectives. ( Bohan, TP; Coulter, DL; De Vivo, DC; Dreifuss, FE; Greenwood, RS; Nordli, DR; Shields, WD; Stafstrom, CE; Tein, I, 1998) |
| "Two adult patients with focal epilepsy who tolerated valproate (VPA) well in different combinations of anticonvulsants developed hyperammonemic encephalopathy when treated with VPA in combination with topiramate (TPM)." | 3.70 | Valproate-induced hyperammonemic encephalopathy in the presence of topiramate. ( Hamer, HM; Knake, S; Rosenow, F; Schomburg, U, 2000) |
| "A 24-years-old woman with epilepsy treated with valproic acid developed disorientation, acalculia, perseveration, slow responsiveness and loss of memory." | 3.70 | [A case report of valproate encephalopathy]. ( Hirata, K; Katayama, S; Miyamoto, M; Miyamoto, T, 1999) |
| "The plasma levels of urea and ammonia were examined in patients with primary generalized epilepsy, patients with partial epilepsy and in the first-degree relatives of these subjects." | 3.68 | Plasma urea and ammonia in epileptic patients and their relatives. ( Hatase, O; Hosokawa, K; Itano, T; Janjua, NA; Kugoh, T; Matsui, H; Tokuda, M, 1992) |
| "Results: Mild cognitive impairment - MCI was diagnosed in 4 patients (28." | 1.72 | HYPERAMMONAEMIA AND COGNITIVE IMPAIRMENT IN EPILEPSY PATIENTS TREATED WITH VALPROIC ACID - PRELIMINARY STUDY. ( Dutkiewicz, J; Pilut, D; Szczygieł-Pilut, EE; Zajączkowska-Dutkiewicz, A, 2022) |
| "Biotinidase deficiency is a treatable cause of infantile epilepsy and the presentation can be nonspecific." | 1.40 | Abnormal cerebrospinal fluid biochemistry in biotinidase deficiency causing diagnostic conundrum. ( Brown, R; Calvin, J; Hogg, S; Krishnakumar, D; Maw, A; Parker, AP, 2014) |
| " Pharmacokinetic parameters are necessary to predict the optimum therapeutic level after administration." | 1.37 | Pharmacokinetics and clinical application of intravenous valproate in Thai epileptic children. ( Bhudhisawadi, K; Chulavatnatol, S; Kaojareon, S; Vaewpanich, J; Visudtibhan, A, 2011) |
| "Transient hyperammonemia was observed in the majority of generalized tonic-clonic seizure patients examined in this study but not in those with other causes of consciousness disturbance." | 1.36 | Postictal transient hyperammonemia as an indicator of seizure disorder. ( Lee, CW; Lin, TJ; Liu, KT; Su, CS; Yang, SC; Yeh, IJ, 2010) |
| "A partial but significant inhibition of convulsions was found in these animals." | 1.31 | Evidence for an involvement of the ammonia-decreasing action of L-arginine in suppressing picrotoxin-induced convulsions in rats and its additive action with diazepam. ( Jayakumar, AR; Vanaja, P, 2001) |
| "Valproic acid (VPA) is an antiepileptic drug widely used in paediatrics." | 1.30 | [Evaluation of the effect of long term valproic acid treatment on plasma levels of carnitine, ammonia and amino acids related to the urea cycle in pediatric epileptic patients]. ( Jiménez, C; Lluch-Fernández, MD; Marchante-Serrano, C; Navarro-Quesada, FJ; Vaquero-Abellán, M, 1997) |
| "Valproic acid (VPA)-induced encephalopathy is a rarely considered side effect, with somnolence, reduced motor activity and severe deterioration of cognitive and behavioural abilities." | 1.30 | [Encephalopathies caused by valproate]. ( Bräunig, P; Göbel, R; Görtzen, A, 1999) |
| " In both group A and group B patients, plasma ammonia levels were correlated with the valproic acid dosage (r = 0." | 1.30 | Carnitine deficiency and hyperammonemia in children receiving valproic acid with and without other anticonvulsant drugs. ( Chiarelli, F; Greco, R; Morgese, G; Verrotti, A, 1999) |
| "Free carnitine was low in tube-fed patients, as compared with that in oral-fed patients." | 1.28 | [The problems of valproate therapy in severely handicapped children--valproate induced hyperammonemia and hypocarnitinemia]. ( Iwamoto, H; Kobayashi, T; Matsui, K; Miyake, S; Ohtsuki, N; Yamada, M, 1991) |
| "5 of these patients developed toxic encephalopathy with hyperammonemia induced by VPA." | 1.27 | Treatment of epileptic patients with valproic acid does not modify plasma and urine short-chain-fatty acids. ( Arnetoli, G; Boncinelli, L; Campostrini, R; Paganini, M; Zaccara, G; Zappoli, R, 1983) |
| " In 8 of them, a therapeutic dosage of VPA caused modifications of the state of consciousness ranging from coma to drowsiness and stupor." | 1.27 | Hyperammonemia and valproate-induced alterations of the state of consciousness. A report of 8 cases. ( Arnetoli, G; Campostrini, R; Moroni, F; Paganini, M; Zaccara, G; Zappoli, R, 1984) |
| "Valproic acid (VPA) was given to 24 epileptic patients who were already being treated with other antiepileptic drugs." | 1.27 | Acute changes of blood ammonia may predict short-term adverse effects of valproic acid. ( Arnetoli, G; Baruzzi, A; Campostrini, R; Moroni, F; Paganini, M; Targioni, G; Valenza, T; Zaccara, G; Zappoli, R, 1984) |
| " Twenty-three patients complained of various long-term adverse effects, while the other 17 remained symptom-free." | 1.27 | Long-term treatment with sodium valproate: monitoring of venous ammonia concentrations and adverse effects. ( Arnetoli, G; Campostrini, R; Messori, A; Paganini, M; Valenza, T; Zaccara, G; Zappoli, R, 1987) |
| "Seventeen patients with partial epilepsy had electroencephalographic (EEG) monitoring concurrent with cerebral positron emission computed tomography (PECT) after 18F-fluorodeoxyglucose (18FDG) and 13N-ammonia (13NH3) were given intravenously as indicators of local cerebral glucose utilization (LCMRglc) and relative perfusion, respectively." | 1.26 | Epileptic patterns of local cerebral metabolism and perfusion in humans determined by emission computed tomography of 18FDG and 13NH3. ( Engel, J; Kuhl, DE; Phelps, ME; Selin, C, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 36 (37.50) | 18.7374 |
| 1990's | 24 (25.00) | 18.2507 |
| 2000's | 11 (11.46) | 29.6817 |
| 2010's | 17 (17.71) | 24.3611 |
| 2020's | 8 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y | 1 |
| Chen, J | 1 |
| Zhuang, X | 1 |
| Chen, X | 1 |
| Zeng, J | 1 |
| Wang, R | 1 |
| Miao, J | 1 |
| Vakrinou, A | 1 |
| Murphy, E | 1 |
| Sisodiya, SM | 1 |
| Vivekananda, U | 1 |
| Balestrini, S | 1 |
| Szczygieł-Pilut, EE | 1 |
| Zajączkowska-Dutkiewicz, A | 1 |
| Pilut, D | 1 |
| Dutkiewicz, J | 1 |
| Hosseini, H | 3 |
| Shafie, M | 3 |
| Shakiba, A | 3 |
| Ghayyem, H | 3 |
| Mayeli, M | 3 |
| Hassani, M | 3 |
| Aghamollaii, V | 3 |
| Kwack, DW | 1 |
| Kim, DW | 1 |
| Yokoyama, S | 2 |
| Yasui-Furukori, N | 1 |
| Nakagami, T | 1 |
| Miyazaki, K | 1 |
| Ishioka, M | 1 |
| Tarakita, N | 1 |
| Kubo, K | 1 |
| Sugawara, N | 1 |
| Shimoda, K | 1 |
| Nilsson, CH | 1 |
| Svensson, MB | 1 |
| Säve, SJ | 1 |
| Van Meervenne, SA | 1 |
| Kopel, J | 1 |
| Grooms, A | 1 |
| Ganapathy, V | 1 |
| Clothier, J | 1 |
| Zhu, X | 1 |
| Li, X | 1 |
| Zhang, T | 1 |
| Zhao, L | 1 |
| Camilleri, L | 1 |
| Nakamura, K | 1 |
| Yamane, K | 1 |
| Shinohara, K | 1 |
| Doi, K | 1 |
| Inokuchi, R | 1 |
| Hiruma, T | 1 |
| Nakajima, S | 1 |
| Noiri, E | 1 |
| Yahagi, N | 1 |
| Vázquez, M | 2 |
| Fagiolino, P | 2 |
| Maldonado, C | 2 |
| Olmos, I | 1 |
| Ibarra, M | 1 |
| Alvariza, S | 1 |
| Guevara, N | 2 |
| Magallanes, L | 1 |
| Olano, I | 1 |
| Inoue, K | 2 |
| Suzuki, E | 2 |
| Takahashi, T | 2 |
| Yamamoto, Y | 2 |
| Yazawa, R | 1 |
| Takahashi, Y | 2 |
| Imai, K | 2 |
| Miyakawa, K | 1 |
| Inoue, Y | 2 |
| Tsuji, D | 2 |
| Hayashi, H | 1 |
| Itoh, K | 2 |
| Tseng, YL | 1 |
| Huang, CR | 1 |
| Lin, CH | 1 |
| Lu, YT | 1 |
| Lu, CH | 1 |
| Chen, NC | 1 |
| Chang, CC | 1 |
| Chang, WN | 1 |
| Chuang, YC | 1 |
| Hirai, K | 1 |
| Queijo, C | 1 |
| González, R | 1 |
| Bayrakli, I | 1 |
| Turkmen, A | 1 |
| Akman, H | 1 |
| Sezer, MT | 1 |
| Kutluhan, S | 1 |
| Guo, X | 1 |
| Gao, L | 1 |
| Lin, W | 1 |
| Wu, Y | 1 |
| Wang, Q | 1 |
| Xing, B | 1 |
| Xu, Z | 1 |
| DeWolfe, JL | 1 |
| Knowlton, RC | 1 |
| Beasley, MT | 1 |
| Cofield, S | 1 |
| Faught, E | 1 |
| Limdi, NA | 1 |
| Hamed, SA | 1 |
| Abdella, MM | 1 |
| Bøhmer, T | 1 |
| Bøen, A | 1 |
| Høymork, SC | 1 |
| Visudtibhan, A | 1 |
| Bhudhisawadi, K | 1 |
| Vaewpanich, J | 1 |
| Chulavatnatol, S | 1 |
| Kaojareon, S | 1 |
| Liu, KT | 1 |
| Lee, CW | 1 |
| Yang, SC | 1 |
| Yeh, IJ | 1 |
| Lin, TJ | 1 |
| Su, CS | 1 |
| Sharma, S | 1 |
| Gulati, S | 1 |
| Kabra, M | 1 |
| Kalra, V | 1 |
| Vasisht, S | 1 |
| Gupta, YK | 1 |
| Eid, T | 1 |
| Behar, K | 1 |
| Dhaher, R | 1 |
| Bumanglag, AV | 1 |
| Lee, TS | 1 |
| Itoh, H | 1 |
| Suzuki, Y | 1 |
| Fujisaki, K | 1 |
| Sato, Y | 1 |
| Takeyama, M | 1 |
| Krishnakumar, D | 1 |
| Maw, A | 1 |
| Brown, R | 1 |
| Hogg, S | 1 |
| Calvin, J | 1 |
| Parker, AP | 1 |
| BARUK, H | 1 |
| FABIANI, P | 1 |
| Latour, P | 1 |
| Biraben, A | 1 |
| Polard, E | 1 |
| Bentué-Ferrer, D | 1 |
| Beauplet, A | 1 |
| Tribut, O | 1 |
| Allain, H | 1 |
| Day, B | 1 |
| Chicharro, AV | 1 |
| de Marinis, AJ | 1 |
| Kanner, AM | 1 |
| Sikma, MA | 1 |
| Mier, JC | 1 |
| Meulenbelt, J | 1 |
| Nicolai, J | 1 |
| Carr, RB | 1 |
| Goto, S | 1 |
| Seo, T | 1 |
| Hagiwara, T | 1 |
| Ueda, K | 1 |
| Yamauchi, T | 1 |
| Nagata, S | 1 |
| Ando, Y | 1 |
| Ishitsu, T | 1 |
| Nakagawa, K | 1 |
| Parikh, S | 1 |
| Cohen, BH | 1 |
| Gupta, A | 1 |
| Lachhwani, DK | 1 |
| Wyllie, E | 2 |
| Kotagal, P | 1 |
| Coulter, DL | 2 |
| Allen, RJ | 1 |
| Kvamme, E | 1 |
| Takei, M | 1 |
| Lux, HD | 1 |
| Marescaux, C | 5 |
| Warter, JM | 4 |
| Laroye, M | 1 |
| Rumbach, L | 4 |
| Micheletti, G | 4 |
| Koehl, C | 2 |
| Imler, M | 4 |
| Kurtz, D | 2 |
| Brandt, C | 2 |
| Chabrier, G | 3 |
| Wyllie, R | 1 |
| Rothner, AD | 1 |
| Erenberg, G | 1 |
| Cruse, RP | 1 |
| Zaccara, G | 6 |
| Boncinelli, L | 1 |
| Paganini, M | 6 |
| Campostrini, R | 6 |
| Arnetoli, G | 5 |
| Zappoli, R | 5 |
| Collard, M | 2 |
| Moroni, F | 2 |
| Valenza, T | 3 |
| Targioni, G | 1 |
| Baruzzi, A | 2 |
| Angelastro, R | 1 |
| Bartelli, M | 1 |
| Hagberg, B | 1 |
| Aicardi, J | 1 |
| Dias, K | 1 |
| Ramos, O | 1 |
| Kuhl, DE | 1 |
| Engel, J | 1 |
| Phelps, ME | 1 |
| Selin, C | 1 |
| Batshaw, ML | 1 |
| Brusilow, SW | 1 |
| Iles, JF | 1 |
| Jack, JJ | 1 |
| Sewell, AC | 2 |
| Böhles, HJ | 1 |
| Herwig, J | 1 |
| Demirkol, M | 1 |
| Baganz, MD | 1 |
| Dross, PE | 1 |
| Sannita, WG | 2 |
| Balestra, V | 1 |
| DiBon, G | 1 |
| Hassan, KM | 1 |
| Rosadini, G | 1 |
| Murakami, K | 1 |
| Sugimoto, T | 1 |
| Woo, M | 1 |
| Nishida, N | 1 |
| Muro, H | 1 |
| Böhles, H | 1 |
| Wenzel, D | 1 |
| Campistol, J | 1 |
| García-García, JJ | 1 |
| Lobera, E | 1 |
| Sanmartí, FX | 1 |
| Conill, J | 1 |
| Fernández-Alvarez, E | 1 |
| Gidal, BE | 1 |
| Inglese, CM | 1 |
| Meyer, JF | 1 |
| Pitterle, ME | 1 |
| Antonopolous, J | 1 |
| Rust, RS | 1 |
| Navarro-Quesada, FJ | 1 |
| Lluch-Fernández, MD | 1 |
| Vaquero-Abellán, M | 1 |
| Marchante-Serrano, C | 1 |
| Jiménez, C | 1 |
| Altunbaşak, S | 1 |
| Baytok, V | 1 |
| Tasouji, M | 1 |
| Hergüner, O | 1 |
| Burgut, R | 1 |
| Kayrin, L | 1 |
| Hirose, S | 1 |
| Mitsudome, A | 1 |
| Yasumoto, S | 1 |
| Ogawa, A | 1 |
| Muta, Y | 1 |
| Tomoda, Y | 1 |
| De Vivo, DC | 1 |
| Bohan, TP | 1 |
| Dreifuss, FE | 1 |
| Greenwood, RS | 1 |
| Nordli, DR | 1 |
| Shields, WD | 1 |
| Stafstrom, CE | 1 |
| Tein, I | 1 |
| Göbel, R | 1 |
| Görtzen, A | 1 |
| Bräunig, P | 1 |
| Verrotti, A | 1 |
| Greco, R | 1 |
| Morgese, G | 1 |
| Chiarelli, F | 1 |
| Hamer, HM | 1 |
| Knake, S | 1 |
| Schomburg, U | 1 |
| Rosenow, F | 1 |
| Miyamoto, T | 1 |
| Miyamoto, M | 1 |
| Hirata, K | 1 |
| Katayama, S | 1 |
| Vanaja, P | 1 |
| Jayakumar, AR | 1 |
| Janjua, N | 1 |
| Itano, T | 2 |
| Kugoh, T | 3 |
| Hosokawa, K | 3 |
| Hatase, O | 2 |
| Janjua, NA | 1 |
| Matsui, H | 1 |
| Tokuda, M | 1 |
| Tokatli, A | 1 |
| Coşkun, T | 1 |
| Cataltepe, S | 1 |
| Ozalp, I | 1 |
| Matsui, K | 1 |
| Iwamoto, H | 1 |
| Ohtsuki, N | 1 |
| Kobayashi, T | 1 |
| Miyake, S | 1 |
| Yamada, M | 1 |
| Thom, H | 1 |
| Carter, PE | 1 |
| Cole, GF | 1 |
| Stevenson, KL | 1 |
| Riva, R | 1 |
| Albani, F | 1 |
| Galli, G | 1 |
| Castro-Gago, M | 1 |
| Rodrigo-Saez, E | 1 |
| Novo-Rodriguez, I | 1 |
| Camiña, MF | 1 |
| Rodriguez-Segade, S | 1 |
| Wiedemann, G | 1 |
| Haupt, M | 1 |
| Rommel, A | 1 |
| Rommel, KF | 1 |
| Biesenbach, R | 1 |
| Schmidt, W | 1 |
| Christmann, D | 1 |
| Hirsch, E | 1 |
| Mutschler, V | 1 |
| Colombo, JP | 1 |
| Komatsu, M | 1 |
| Kodama, S | 1 |
| Konishi, H | 1 |
| Tanaka, K | 1 |
| Momota, K | 1 |
| Wada, H | 1 |
| Matsuo, T | 1 |
| Matsuda, I | 1 |
| Ohtani, Y | 1 |
| Ninomiya, N | 1 |
| Laub, MC | 1 |
| Ettlin, T | 1 |
| Scollo-Lavizzari, G | 1 |
| Messori, A | 1 |
| Yamamoto, M | 1 |
| Iinuma, K | 1 |
| Hayasaka, K | 1 |
| Narisawa, K | 1 |
| Tada, K | 1 |
| Hori, K | 1 |
| Haidukewych, D | 1 |
| John, G | 1 |
| Zielinski, JJ | 1 |
| Rodin, EA | 1 |
| Kanayama, M | 1 |
| Sugiyama, N | 1 |
| Morishita, H | 1 |
| Ishikawa, T | 1 |
| Wada, Y | 1 |
| Akiyama, T | 1 |
| Fridliandskiĭ, AI | 1 |
| Fridlianskiĭ, AI | 1 |
| Lamotte, M | 1 |
| Segrestaa, JM | 1 |
| Caulin, C | 1 |
| Hugues, FC | 1 |
| Brenton, DP | 1 |
| Cusworth, DC | 1 |
| Hartley, S | 1 |
| Lumley, S | 1 |
| Kuzemko, JA | 1 |
| Wright, T | 1 |
| Pollitt, R | 1 |
| Tudor, I | 1 |
| Kolpakov, VG | 1 |
| Nedbal, J | 1 |
| Khodos, KhG | 1 |
| Kozarenko, TD | 1 |
| Okladnikov, VI | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Rett Syndrome, MECP2 Duplication Disorder, and Rett- Related Disorders Natural History Protocol[NCT02738281] | 1,044 participants (Actual) | Observational | 2015-11-30 | Completed | |||
| Biobanking of Rett Syndrome and Related Disorders Protocol[NCT02705677] | 752 participants (Actual) | Observational | 2017-09-01 | Completed | |||
| Investigation on the Effects of an Osteopathic Manipulative Treatment for Constipation in People With Rett Syndrome[NCT05687214] | 12 participants (Actual) | Interventional | 2022-11-16 | Completed | |||
| Effect of Adding Lamotrigine to Sodium Valproate in Childhood Epilepsy: Clinicolabratory Study[NCT05881928] | Phase 4 | 50 participants (Anticipated) | Interventional | 2023-07-25 | Not yet recruiting | ||
| Estudio clínico Fase III Para Evaluar la Eficacia terapéutica en Pacientes Mexicanos Con Dislipidemia Mediante el Uso vía Oral de L-Carnitina + Atorvastatina Comparado Con Atorvastatina[NCT03696940] | Phase 3 | 120 participants (Actual) | Interventional | 2018-05-28 | Active, not recruiting | ||
| Valproic Acid-associated Hypoalbuminemia in Medically Fragile Pediatric and Young Adult Patients in a Long Term Care Facility Part 1: Potential Mechanism for Decreased Albumin Synthesis[NCT00723762] | 90 participants (Anticipated) | Observational | 2009-02-28 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
8 reviews available for ammonium hydroxide and Aura
| Article | Year |
|---|---|
Risk factors and outcome of hyperammonaemia in people with epilepsy.
Topics: Adult; Ammonia; Epilepsy; Humans; Hyperammonemia; Observational Studies as Topic; Oxcarbazepine; Ris | 2022 |
Risk factors of hyperammonemia in epilepsy patients with valproic acid therapy.
Topics: Adult; Ammonia; Anticonvulsants; Epilepsy; Humans; Hyperammonemia; Risk Factors; Topiramate; Valproi | 2023 |
Lesson of the month 1: Sodium valproate-induced encephalopathy.
Topics: Aged; Ammonia; Anticonvulsants; Brain Diseases; Carnitine; Consciousness Disorders; Epilepsy; Humans | 2018 |
Roles of glutamine synthetase inhibition in epilepsy.
Topics: Ammonia; Animals; Epilepsy; gamma-Aminobutyric Acid; Glutamate-Ammonia Ligase; Glutamic Acid; Glutam | 2012 |
The measurement of ammonia blood levels in patients taking valproic acid: looking for problems where they do not exist?
Topics: Ammonia; Anticonvulsants; Epilepsy; Female; Humans; Male; MEDLINE; Retrospective Studies; Valproic A | 2007 |
Ionic conditions and membrane behavior.
Topics: Ammonia; Animals; Calcium; Cerebral Cortex; Epilepsy; Ion Channels; Ions; Membrane Potentials; Membr | 1980 |
[Late diagnosis of congenital argininemia during administration of sodium valproate].
Topics: Adolescent; Amino Acid Metabolism, Inborn Errors; Ammonia; Arginine; Epilepsy; Female; Humans; Psych | 1990 |
[Biochemical aspects of seizures in convulsive diseases].
Topics: Ammonia; Animals; Biochemical Phenomena; Biochemistry; Cell Membrane; Epilepsy; Fatty Acids; Humans; | 1969 |
5 trials available for ammonium hydroxide and Aura
| Article | Year |
|---|---|
Carnitine and/or Acetylcarnitine Deficiency as a Cause of Higher Levels of Ammonia.
Topics: Acetylcarnitine; Adolescent; Adult; Aged; Aged, 80 and over; Ammonia; Bipolar Disorder; Carnitine; E | 2016 |
Hyperammonemia following intravenous valproate loading.
Topics: Adult; Aged; Ammonia; Analysis of Variance; Anticonvulsants; Bilirubin; Dose-Response Relationship, | 2009 |
The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: relationship to blood carnitine status.
Topics: Adolescent; Ammonia; Anticonvulsants; Carnitine; Child; Epilepsy; Female; Humans; Hyperammonemia; Ma | 2009 |
Potential relationships between transaminase abnormality and valproic acid clearance or serum carnitine concentrations in Japanese epileptic patients.
Topics: Adolescent; Adult; Ammonia; Anticonvulsants; Body Weight; Carnitine; Chemical and Drug Induced Liver | 2008 |
The effect of carnitine supplementation in valproate-induced hyperammonaemia.
Topics: Adolescent; Adult; Ammonia; Anticonvulsants; Carnitine; Chemical and Drug Induced Liver Injury; Chil | 1996 |
83 other studies available for ammonium hydroxide and Aura
| Article | Year |
|---|---|
Risk factors of elevated blood ammonia level in epilepsy patients treated with lamotrigine.
Topics: Ammonia; Anticonvulsants; Epilepsy; Humans; Hyperammonemia; Lamotrigine; Risk Factors; Seizures; Tri | 2022 |
HYPERAMMONAEMIA AND COGNITIVE IMPAIRMENT IN EPILEPSY PATIENTS TREATED WITH VALPROIC ACID - PRELIMINARY STUDY.
Topics: Ammonia; Anticonvulsants; Cognitive Dysfunction; Dementia; Epilepsy; Female; Humans; Hyperammonemia; | 2022 |
Valproic acid-induced hyperammonemia in neuropsychiatric disorders: a 2-year clinical survey.
Topics: Ammonia; Anticonvulsants; Epilepsy; Humans; Hyperammonemia; Risperidone; Valproic Acid | 2023 |
Valproic acid-induced hyperammonemia in neuropsychiatric disorders: a 2-year clinical survey.
Topics: Ammonia; Anticonvulsants; Epilepsy; Humans; Hyperammonemia; Risperidone; Valproic Acid | 2023 |
Valproic acid-induced hyperammonemia in neuropsychiatric disorders: a 2-year clinical survey.
Topics: Ammonia; Anticonvulsants; Epilepsy; Humans; Hyperammonemia; Risperidone; Valproic Acid | 2023 |
Valproic acid-induced hyperammonemia in neuropsychiatric disorders: a 2-year clinical survey.
Topics: Ammonia; Anticonvulsants; Epilepsy; Humans; Hyperammonemia; Risperidone; Valproic Acid | 2023 |
Association Between the Serum Carnitine Level and Ammonia and Valproic Acid Levels in Patients with Bipolar Disorder.
Topics: Ammonia; Anticonvulsants; Bipolar Disorder; Carnitine; Epilepsy; Female; Humans; Male; Middle Aged; | 2020 |
Transient hyperammonaemia following epileptic seizures in cats.
Topics: Ammonia; Animals; Cat Diseases; Cats; Epilepsy; Hyperammonemia; Retrospective Studies; Seizures | 2021 |
Metformin, valproic acid, and starvation induce seizures in a patient with partial SLC13A5 deficiency: a case of pharmaco-synergistic heterozygosity.
Topics: Adult; Amino Acid Substitution; Ammonia; Animals; Anticonvulsants; Autistic Disorder; Bipolar Disord | 2021 |
Risk Factors for Valproic Acid-induced Hyperammonaemia in Chinese Paediatric Patients with Epilepsy.
Topics: Age Factors; Ammonia; Anticonvulsants; Aspartate Aminotransferases; Chemical and Drug Induced Liver | 2018 |
Hyperammonemia in idiopathic epileptic seizure.
Topics: Acid-Base Imbalance; Adult; Ammonia; Emergency Service, Hospital; Epilepsy; Female; Humans; Hydrogen | 2013 |
Hyperammonemia associated with valproic acid concentrations.
Topics: Adolescent; Adult; Ammonia; Bipolar Disorder; Carnitine; Child; Dietary Supplements; Dose-Response R | 2014 |
4217C>A polymorphism in carbamoyl-phosphate synthase 1 gene may not associate with hyperammonemia development during valproic acid-based therapy.
Topics: Alleles; Amino-Acid N-Acetyltransferase; Ammonia; Anticonvulsants; Asian People; Biomarkers, Pharmac | 2014 |
Risk factors of hyperammonemia in patients with epilepsy under valproic acid therapy.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Ammonia; Anticonvulsants; Antipsychotic Age | 2014 |
Influence of glutamine synthetase gene polymorphisms on the development of hyperammonemia during valproic acid-based therapy.
Topics: Adolescent; Ammonia; Anticonvulsants; Child; Child, Preschool; Epilepsy; Female; Genotype; Glutamate | 2015 |
Applications of external cavity diode laser-based technique to noninvasive clinical diagnosis using expired breath ammonia analysis: chronic kidney disease, epilepsy.
Topics: Ammonia; Breath Tests; Epilepsy; Humans; Lasers, Semiconductor; Renal Insufficiency, Chronic | 2016 |
Hyperammonemia induced by prophylactic administration of antiepileptic drugs during the perioperative period of craniotomy.
Topics: Ammonia; Anticonvulsants; Chemoprevention; Craniotomy; Epilepsy; Female; Humans; Hyperammonemia; Mal | 2016 |
Valproate-induced hyperammonemic encephalopathy, rapidly improved by i.v. carnitine and glucose/thiamine.
Topics: Aged; Ammonia; Anticonvulsants; Brain Diseases, Metabolic; Carnitine; Dose-Response Relationship, Dr | 2010 |
Pharmacokinetics and clinical application of intravenous valproate in Thai epileptic children.
Topics: Adolescent; Ammonia; Anticonvulsants; Child; Child, Preschool; Cross-Sectional Studies; Epilepsy; Fe | 2011 |
Postictal transient hyperammonemia as an indicator of seizure disorder.
Topics: Aged; Aged, 80 and over; Ammonia; Epilepsy; Female; Follow-Up Studies; Humans; Hyperammonemia; Male; | 2010 |
Blood ammonia levels in epileptic children on 2 dose ranges of valproic acid monotherapy: a cross-sectional study.
Topics: Ammonia; Anticonvulsants; Child; Child, Preschool; Cross-Sectional Studies; Epilepsy; Fluorescence P | 2011 |
Correlation between plasma ammonia level and serum trough concentration of free valproic acid in patients with epilepsy.
Topics: Adolescent; Adult; Ammonia; Anticonvulsants; Asian People; Child; Child, Preschool; Epilepsy; Female | 2012 |
Abnormal cerebrospinal fluid biochemistry in biotinidase deficiency causing diagnostic conundrum.
Topics: Ammonia; Biotinidase Deficiency; Electroencephalography; Epilepsy; Female; Humans; Infant; Lactic Ac | 2014 |
[Study of blood ammonia in periodic psychosis and in the epileptic state. Psychotoxic value of certain digestive disorders therapeutic trials].
Topics: Ammonia; Catatonia; Epilepsy; Gastroenterology; Humans; Mental Disorders; Peptides; Psychoses, Subst | 1962 |
Drug induced encephalopathy in six epileptic patients: topiramate? valproate? or both?
Topics: Adolescent; Adult; Ammonia; Anticonvulsants; Drug Interactions; Drug Therapy, Combination; Electroen | 2004 |
Spike-wave stupor in a patient with metabolic encephalopathy.
Topics: Ammonia; Anticonvulsants; Brain Diseases, Metabolic; Coma; Diagnosis, Differential; Diazepam; Electr | 2007 |
Massive valproic acid overdose, a misleading case.
Topics: Adult; Ammonia; Anticonvulsants; Antidotes; Charcoal; Coma; Drug Overdose; Epilepsy; Humans; Male; P | 2008 |
The measurement of ammonia blood levels in patients taking valproic acid: looking for problems where they do not exist?
Topics: Ammonia; Anticonvulsants; Epilepsy; Humans; Valproic Acid | 2008 |
Metabolic testing in the pediatric epilepsy unit.
Topics: Adolescent; Adult; Amino Acids; Ammonia; Carnitine; Child; Child, Preschool; Electroencephalography; | 2008 |
Secondary hyperammonaemia: a possible mechanism for valproate encephalopathy.
Topics: Ammonia; Brain; Brain Diseases; Child, Preschool; Epilepsy; Female; Humans; Propionates; Valproic Ac | 1980 |
Ammonia metabolism in the CNS.
Topics: Acyltransferases; Amidohydrolases; Ammonia; Animals; Asparaginase; Brain; Cats; Central Nervous Syst | 1983 |
[Anticonvulsant: a possible cause of abnormal nitrogen metabolism in epileptics with severe physical and mental disabilities].
Topics: Adolescent; Adult; Ammonia; Anticonvulsants; Child; Disabled Persons; Epilepsy; Female; Humans; Inte | 1983 |
[Sodium valproate: a hyperammonemic drug. Study in the epileptic and healthy volunteer].
Topics: Ammonia; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; | 1983 |
Sodium valproate associated with phenobarbital: effects on ammonia metabolism in humans.
Topics: Adult; Ammonia; Epilepsy; Female; Humans; Kidney; Liver; Male; Middle Aged; Phenobarbital; Valproic | 1983 |
Valproate-induced hyperammonemia in asymptomatic children.
Topics: Adolescent; Adult; Ammonia; Child; Child, Preschool; Epilepsy; Humans; Infant; Liver; Valproic Acid | 1983 |
Treatment of epileptic patients with valproic acid does not modify plasma and urine short-chain-fatty acids.
Topics: Adolescent; Adult; Ammonia; Brain Diseases; Butyrates; Epilepsy; Fatty Acids; Female; Hemiterpenes; | 1983 |
[Role of hyperammonemia in stuporous states induced by sodium valproate].
Topics: Adult; Ammonia; Epilepsies, Partial; Epilepsy; Epilepsy, Temporal Lobe; Female; Glutamine; Humans; U | 1983 |
Hyperammonemia and valproate-induced alterations of the state of consciousness. A report of 8 cases.
Topics: Adult; Ammonia; Epilepsy; Female; Humans; Male; Unconsciousness; Valproic Acid | 1984 |
Acute changes of blood ammonia may predict short-term adverse effects of valproic acid.
Topics: Adolescent; Adult; Ammonia; Child; Consciousness Disorders; Epilepsy; Female; Humans; Male; Middle A | 1984 |
Venous blood ammonia concentrations in adult epileptic patients are increased by treatment with valproic acid.
Topics: Adult; Ammonia; Epilepsy; Female; Humans; Male; Middle Aged; Valproic Acid | 1984 |
A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases.
Topics: Adolescent; Adult; Ammonia; Apraxias; Ataxia; Autistic Disorder; Child; Child Development; Child, Pr | 1983 |
A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases.
Topics: Adolescent; Adult; Ammonia; Apraxias; Ataxia; Autistic Disorder; Child; Child Development; Child, Pr | 1983 |
A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases.
Topics: Adolescent; Adult; Ammonia; Apraxias; Ataxia; Autistic Disorder; Child; Child Development; Child, Pr | 1983 |
A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases.
Topics: Adolescent; Adult; Ammonia; Apraxias; Ataxia; Autistic Disorder; Child; Child Development; Child, Pr | 1983 |
A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases.
Topics: Adolescent; Adult; Ammonia; Apraxias; Ataxia; Autistic Disorder; Child; Child Development; Child, Pr | 1983 |
A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases.
Topics: Adolescent; Adult; Ammonia; Apraxias; Ataxia; Autistic Disorder; Child; Child Development; Child, Pr | 1983 |
A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases.
Topics: Adolescent; Adult; Ammonia; Apraxias; Ataxia; Autistic Disorder; Child; Child Development; Child, Pr | 1983 |
A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases.
Topics: Adolescent; Adult; Ammonia; Apraxias; Ataxia; Autistic Disorder; Child; Child Development; Child, Pr | 1983 |
A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases.
Topics: Adolescent; Adult; Ammonia; Apraxias; Ataxia; Autistic Disorder; Child; Child Development; Child, Pr | 1983 |
Epileptic patterns of local cerebral metabolism and perfusion in humans determined by emission computed tomography of 18FDG and 13NH3.
Topics: Adolescent; Adult; Ammonia; Brain; Child; Child, Preschool; Epilepsies, Partial; Epilepsy; Glucose; | 1980 |
Valproate-induced hyperammonemia.
Topics: Adolescent; Amino Acid Metabolism, Inborn Errors; Ammonia; Anticonvulsants; Carbamoyl-Phosphate Synt | 1982 |
Ammonia: assessment of its action on postsynaptic inhibition as a cause of convulsions.
Topics: Ammonia; Animals; Brain; Cats; Dose-Response Relationship, Drug; Epilepsy; Motor Neurons; Neural Con | 1980 |
Neurological deterioration in patients with urea cycle disorders under valproate therapy--a cause for concern.
Topics: Adolescent; Amino Acid Metabolism, Inborn Errors; Ammonia; Arginine; Child; Epilepsy; Female; Humans | 1995 |
Valproic acid-induced hyperammonemic encephalopathy: MR appearance.
Topics: Adult; Ammonia; Atrophy; Brain Diseases, Metabolic; Cerebral Cortex; Diagnosis, Differential; Epilep | 1994 |
Ammonia-independent modifications of the background EEG signal and paradoxical enhancement of epileptic abnormalities in EEG after acute administration of valproate to epileptic patients.
Topics: Adolescent; Adult; Ammonia; Arousal; Blood Glucose; Blood Pressure; Electroencephalography; Epilepsy | 1993 |
Effect of L-carnitine supplementation on acute valproate intoxication.
Topics: Ammonia; Carnitine; Coma; Drug Overdose; Epilepsy; Humans; Infant; Male; Oxidation-Reduction; Valpro | 1996 |
[The Ohtahara's syndrome: a special form of age-dependent epilepsy].
Topics: Adrenocorticotropic Hormone; Age of Onset; Ammonia; Brain; Electroencephalography; Epilepsy; Female; | 1997 |
Diet- and valproate-induced transient hyperammonemia: effect of L-carnitine.
Topics: Administration, Oral; Adolescent; Ammonia; Anticonvulsants; Carnitine; Child; Diet; Epilepsy; Female | 1997 |
[Evaluation of the effect of long term valproic acid treatment on plasma levels of carnitine, ammonia and amino acids related to the urea cycle in pediatric epileptic patients].
Topics: Adolescent; Amino Acids; Ammonia; Anticonvulsants; Carnitine; Child; Child, Preschool; Epilepsy; Glu | 1997 |
Asymptomatic hyperammonemia in children treated with valproic acid.
Topics: Adolescent; Adult; Ammonia; Anticonvulsants; Carnitine; Child; Child, Preschool; Epilepsy; Female; H | 1997 |
Valproate therapy does not deplete carnitine levels in otherwise healthy children.
Topics: Adolescent; Adult; Ammonia; Carnitine; Case-Control Studies; Child; Epilepsy; Female; Humans; Male; | 1998 |
L-carnitine supplementation in childhood epilepsy: current perspectives.
Topics: Age Factors; Ammonia; Anticonvulsants; Carnitine; Chemical and Drug Induced Liver Injury; Child; Chi | 1998 |
[Encephalopathies caused by valproate].
Topics: Adult; Ammonia; Anticonvulsants; Brain Diseases; Drug Interactions; Epilepsy; Humans; Middle Aged; V | 1999 |
Carnitine deficiency and hyperammonemia in children receiving valproic acid with and without other anticonvulsant drugs.
Topics: Adolescent; Adult; Ammonia; Anticonvulsants; Carnitine; Child; Child, Preschool; Epilepsy; Female; H | 1999 |
Valproate-induced hyperammonemic encephalopathy in the presence of topiramate.
Topics: Adult; Ammonia; Anticonvulsants; Brain Diseases; Drug Therapy, Combination; Electroencephalography; | 2000 |
[A case report of valproate encephalopathy].
Topics: Adult; Ammonia; Anticonvulsants; Biomarkers; Brain; Brain Diseases; Carnitine; Epilepsy; Female; Hum | 1999 |
Evidence for an involvement of the ammonia-decreasing action of L-arginine in suppressing picrotoxin-induced convulsions in rats and its additive action with diazepam.
Topics: Ammonia; Animals; Arginine; Brain; Diazepam; Drug Interactions; Epilepsy; GABA Antagonists; GABA Mod | 2001 |
Valproate acute administration, EEG epileptic abnormalities, and ammonemia.
Topics: Adolescent; Adult; Ammonia; Electroencephalography; Epilepsy; Female; Humans; Male; Valproic Acid | 1992 |
Low urea and high ammonia levels in plasma in epileptic patients and their relatives.
Topics: Adolescent; Adult; Ammonia; Child; Epilepsy; Female; Humans; Male; Middle Aged; Urea | 1992 |
Plasma urea and ammonia in epileptic patients and their relatives.
Topics: Adolescent; Adult; Amino Acids; Ammonia; Child; Citrulline; Epilepsy; Family; Female; Humans; Male; | 1992 |
Valproate-induced lethal hyperammonaemic coma in a carrier of ornithine carbamoyltransferase deficiency.
Topics: Ammonia; Child, Preschool; Coma; Epilepsy; Female; Heterozygote; Humans; Ornithine Carbamoyltransfer | 1991 |
[The problems of valproate therapy in severely handicapped children--valproate induced hyperammonemia and hypocarnitinemia].
Topics: Adolescent; Adult; Ammonia; Carnitine; Child; Child, Preschool; Disabled Persons; Enteral Nutrition; | 1991 |
Ammonia and carnitine concentrations in children treated with sodium valproate compared with other anticonvulsant drugs.
Topics: Adolescent; Ammonia; Anticonvulsants; Carnitine; Child; Child, Preschool; Epilepsy; Erythrocytes; Fe | 1991 |
Effects of acute valproic acid administration on carnitine plasma concentrations in epileptic patients.
Topics: Adult; Ammonia; Carnitine; Epilepsy; Humans; Phenobarbital; Phenytoin; Valproic Acid | 1991 |
Hyperaminoacidemia in epileptic children treated with valproic acid.
Topics: Adolescent; Amino Acids; Ammonia; Child; Child, Preschool; Epilepsy; Humans; Infant; Valproic Acid | 1990 |
[Incidence of pathologic ammonia concentrations in the plasma in children with seizure disorders treated with Convulsofin/Convulex and other anticonvulsants in comparison with children with brain damage and healthy children].
Topics: Adolescent; Ammonia; Anticonvulsants; Brain Damage, Chronic; Chemical and Drug Induced Liver Injury; | 1990 |
Valproate-associated hyperammonemia and DL-carnitine supplement.
Topics: Adolescent; Adult; Ammonia; Carbamazepine; Carnitine; Child; Child, Preschool; Disabled Persons; Dru | 1987 |
Renal handling of carnitine in children with carnitine deficiency and hyperammonemia associated with valproate therapy.
Topics: Ammonia; Carnitine; Epilepsy; Humans; Infant; Intellectual Disability; Kidney; Metabolic Clearance R | 1986 |
[Hyperammonemia in valproate therapy in children and adolescents].
Topics: Adolescent; Ammonia; Anticonvulsants; Child; Drug Therapy, Combination; Epilepsy; Female; Humans; Ma | 1986 |
[Hyperammonemia during sodium valproate therapy: clinically relevant or accidental finding?].
Topics: Adult; Aged; Ammonia; Epilepsy; Female; Humans; Male; Middle Aged; Valproic Acid | 1986 |
Long-term treatment with sodium valproate: monitoring of venous ammonia concentrations and adverse effects.
Topics: Adolescent; Adult; Alopecia; Ammonia; Body Weight; Child; Epilepsy; Female; Gastrointestinal Disease | 1987 |
Blood ammonia level during valproic acid therapy.
Topics: Adolescent; Adult; Ammonia; Child; Child, Preschool; Drug Therapy, Combination; Epilepsy; Female; Hu | 1986 |
Hyperamino-acidaemia and hyperammonaemia in epileptic children treated with valproic acid.
Topics: Adolescent; Amino Acids; Ammonia; Child; Child, Preschool; Epilepsy; Humans; Infant; Valproic Acid | 1988 |
Adaptation of hepatic ammonia metabolism after chronic valproate administration in epileptics treated with phenytoin.
Topics: Adaptation, Physiological; Adult; Ammonia; Drug Interactions; Drug Therapy, Combination; Epilepsy; H | 1985 |
Chronic valproic acid therapy and incidence of increases in venous plasma ammonia.
Topics: Adolescent; Adult; Aged; Ammonia; Carbamazepine; Child; Child, Preschool; Drug Interactions; Epileps | 1985 |
[Effects of valproate on mitochondrial function in epileptic patients].
Topics: Adolescent; Ammonia; Carnitine; Child; Child, Preschool; Epilepsy; Humans; Lactates; Lactic Acid; Mi | 1985 |
[The dynamics of various metabolic indices in epileptic patients during therapeutic remission].
Topics: Alpha-Globulins; Ammonia; Beta-Globulins; Blood Proteins; Brain Chemistry; Epilepsy; Female; gamma-G | 1972 |
[Partial and complete discontinuation of treatment in epilepsy].
Topics: Adult; Ammonia; Anticonvulsants; Blood Proteins; Electroencephalography; Epilepsy; Epilepsy, Absence | 1973 |
[The neuro-psychic complications of chronic alcoholism].
Topics: Adolescent; Adult; Aged; Alcoholism; Ammonia; Brain; Brain Chemistry; Chronic Disease; Citric Acid C | 1968 |
Argininosuccinicaciduria: clinical, metabolic and dietary study.
Topics: Affective Symptoms; Amino Acid Metabolism, Inborn Errors; Ammonia; Arginase; Arginine; Ataxia; Child | 1974 |
Psychomotor retardation, epileptic and stuporous attacks, irritability and ataxia associated with ammonia intoxication, high blood ornithine levels and increased homocitruline in the urine.
Topics: Adult; Amino Acid Metabolism, Inborn Errors; Ammonia; Ataxia; Citrulline; Epilepsy; Female; Humans; | 1973 |
[On the probable pathogenetic mechanisms of epilepsy].
Topics: 5-Hydroxytryptophan; Alanine; Ammonia; Animals; Asparagine; Carboxy-Lyases; Epilepsy; Glutamates; Li | 1967 |
[The effect of olfactory stimuli on the seizure disposition in epilepsy].
Topics: Adult; Ammonia; Electroencephalography; Epilepsy; Epilepsy, Temporal Lobe; Female; Humans; Menthol; | 1967 |
[Amino acid content in the cerebrospinal fluid in epilepsy].
Topics: Amino Acids; Ammonia; Asparagine; Chromatography, Ion Exchange; Epilepsy; Glutamates; Histidine; Hum | 1965 |